Samalizumab

samalizumab · Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Samalizumab, covering 2018-07-18 to 2019-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Dose Ranging Study of Samalizumab to Treat Relapsing or Refractory CLL or MM [Phase 1, Phase 2]